PI3K-Mediated Blimp-1 Activation Controls B Cell Selection and Homeostasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PI3K-Mediated Blimp-1 Activation Controls B Cell Selection and Homeostasis

Published:2018-07 Issue:2 Volume:24 Page:391-405
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Setz Corinna S.,Hug Eva,Khadour Ahmad,Abdelrasoul Hend,Bilal Mayas,Hobeika Elias,Jumaa Hassan

Funder

TRR130

ERC

Egyptian Ministry of Higher Education

German Academic Exchange Service

German-Egyptian Research Long Term Scholarship Program (GERLS

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference47 articles.

1. FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination;Alkhatib;J. Exp. Med.,2012

2. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B;Anderson;Curr. Biol.,1998

3. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis;Bagger;Nucleic Acids Res.,2016

4. Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma;Calado;Cancer Cell,2010

5. B cell receptor signal strength determines B cell fate;Casola;Nat. Immunol.,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies;Expert Review of Anticancer Therapy;2024-05-08

2. B-1a Cells, but Not Marginal Zone B Cells, Are Implicated in the Accumulation of Autoreactive Plasma Cells in Lyn−/− Mice;ImmunoHorizons;2024-01-01

3. The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia;Annals of Hematology;2023-07-08

4. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia;Leukemia;2023-01-20

5. Genetic Modeling of B-cell State Transitions for Rational Design of Lymphoma Therapies;Blood Cancer Discovery;2022-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3